Almi Invest's Biotechnology Portfolio

EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.

Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.

Seaqure Labs is a biotech startup utilizing mycoproteins as the solution for current unsustainable methods within aquaculture.

TrackPaw Scientific specializes in the creation and commercialization of a technology platform to accelerate medication developmen

Ecohelix is a Swedish greentech company leading the way in sustainable wood-based biopolymer technology

OssDsign is a medical-technology company developing implants for bone replacement.

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Epigenica offers the EpiFinder platform for high-throughput epigenetic analysis and R&D services in therapeutic and diagnostic development.

Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity.

SINGLE TECHNOLOGIES develops a new type of (3-D) DNA sequencing system to improve Life.

UTI-lizer develops diagnostic tests for urinary tract infections.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

GAIA BioMaterials is the manufacturer of a bio-degradable product that offers pouch, tray, and bottle products.

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Molecular Attraction is a bio-attractant discovery company.

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).

Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.

Amferia is a startup manufacturing medical materials that actively prevents infections.

Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.

Cubase Bio is a biotechnology business that focuses on spatial biology tools.

Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic.

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid.

Alertix is a healthcare platform.

Empe Diagnostics develops diagnostic solutions for infectious diseases with a special focus on antimicrobial resistance.

BioReperia is a start-up service company that develops new products for accelerating drug discovery.